Hello and Welcome to Patientsville.com, Your Source for all SEROPLEX information. We are dedicated to provide You with SEROPLEX safety information. Learn about SEROPLEX serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEROPLEX Safety Reports
Total SEROPLEX reports: 109.SEROPLEX FDA safety alerts: No.
Reported deaths: 14 Reported hospitalizations: 58.
Take SEROPLEX Side Effects Survey or Share Your SEROPLEX Story. Read More Here.
Showing 1-75 of 109 Next >
Consumer or non-health professional from FRANCE reported SEROPLEX problem on Oct 13, 2006. Female patient, 62 years of age, was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema. SEROPLEX dosage: unknown. Patient recovered.SEROPLEX problem was reported by a Consumer or non-health professional from FRANCE on Oct 12, 2006. Male patient, 41 years of age, weighting 143.3 lb, was diagnosed with major depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: completed suicide, delirium, euphoric mood, gun shot wound, homicide, major depression, marital problem. SEROPLEX dosage: 10 MG QD PO. During the same period patient was treated with PRAZEPAM. Patient died on 09/18/2006.
Consumer or non-health professional from FRANCE reported SEROPLEX problem on Oct 11, 2006. Female patient, 82 years of age, was diagnosed with depression, diabetes mellitus and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, hypokalaemia, hyponatraemia. SEROPLEX dosage: 10 MG QD PO. During the same period patient was treated with GLICLAZIDE, METFORMIN. Patient was hospitalized. Patient recovered.
SEROPLEX problem was reported by a Health Professional from FRANCE on Oct 13, 2006. Male patient, 33 years of age, weighting 132.3 lb, was diagnosed with depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: arthralgia, basophil count increased, chromaturia, differential white blood cell count abnormal, hepatitis, hyperhidrosis, lymphocyte count increased, monocyte count increased, splenomegaly. SEROPLEX dosage: 20 MG QD PO. During the same period patient was treated with ATARAX. Patient recovered.
Health Professional from FRANCE reported SEROPLEX problem on Oct 18, 2006. Male patient, 50 years of age, was diagnosed with depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: chest pain, coronary artery thrombosis. SEROPLEX dosage: 10 MG QD PO. Patient was hospitalized. Patient recovered.
SEROPLEX problem was reported by a Health Professional from FRANCE on Sept 04, 2006. Male patient, 77 years of age, weighting 141.1 lb, was diagnosed with depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: prostatic specific antigen increased, urinary retention. SEROPLEX dosage: 10 MG QD PO. During the same period patient was treated with MOCLAMINE, COLCHICINE, TRANXENE, ZYPREXA. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported SEROPLEX problem on Oct 25, 2006. Male patient was diagnosed with depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: confusional state, incorrect dose administered, speech disorder. SEROPLEX dosage: 10 MG QD PO. During the same period patient was treated with HEMIDIGOXINE, PREVISCAN, RABEPRAZOLE, MOTILIUM. Patient was hospitalized. Patient recovered.
SEROPLEX problem was reported by a Health Professional from FRANCE on Oct 18, 2006. Male patient was diagnosed with abnormal behaviour and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: dementia, parkinsonism, prescribed overdose. SEROPLEX dosage: 30 MG QD PO. During the same period patient was treated with ZYPREXA. Patient was hospitalized. Patient recovered.
Pharmacist from FRANCE reported SEROPLEX problem on Oct 16, 2006. Female patient, weighting 4.63 lb, was diagnosed with major depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: premature baby. SEROPLEX dosage: 20 MG QD TRANSPLACENTAL. Patient was hospitalized. Patient recovered.
SEROPLEX problem was reported by a Pharmacist from FRANCE on Oct 16, 2006. Female patient was diagnosed with major depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: pregnancy, premature baby. SEROPLEX dosage: 5 MG QD PO. Patient was hospitalized. Patient recovered.
Pharmacist from FRANCE reported SEROPLEX problem on Oct 17, 2006. Female patient, 57 years of age, was diagnosed with depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: parkinsonism. SEROPLEX dosage: 10 MG QD PO. During the same period patient was treated with ANTIHYPERTENSIVES. Patient recovered.
SEROPLEX problem was reported by a Pharmacist from FRANCE on Oct 17, 2006. Female patient, 27 years of age, was diagnosed with depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: cytolytic hepatitis, intentional overdose, suicide attempt. SEROPLEX dosage: 10 MG QD PO. During the same period patient was treated with FLUDROCORTISONE, HYDROCORTISONE. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported SEROPLEX problem on Oct 24, 2006. Female patient, 20 years of age, was diagnosed with depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: agitation, parasomnia, sleep walking. SEROPLEX dosage: 10 MG QD PO. During the same period patient was treated with TRILEPTAL. Patient recovered.
SEROPLEX problem was reported by a Physician from FRANCE on Oct 26, 2006. Male patient, 51 years of age, weighting 163.1 lb, was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: haematospermia. SEROPLEX dosage: 10 MG QD PO. Patient recovered.
Health Professional from FRANCE reported SEROPLEX problem on Oct 26, 2006. Male patient, 53 years of age, was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: abdominal pain, acute respiratory distress syndrome, cholestasis, coagulopathy, cytolytic hepatitis, haemodynamic instability, hepatic failure, hepatic pain, hepatic steatosis. SEROPLEX dosage: unknown. During the same period patient was treated with OXAZEPAM. Patient died on 05/18/2006.
SEROPLEX problem was reported by a Health Professional from FRANCE on Nov 02, 2006. Male patient, 81 years of age, weighting 158.7 lb, was diagnosed with depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: confusional state, incorrect dose administered, speech disorder. SEROPLEX dosage: 10 MG QD PO. During the same period patient was treated with HEMIDIGOXINE, PREVISCAN, RABEPRAZOLE, MOTILIUM, ZOLPIDEM TARTRATE. Patient was hospitalized and became disabled. Patient recovered.
Pharmacist from FRANCE reported SEROPLEX problem on Nov 20, 2006. Male patient, 51 years of age, weighting 163.1 lb, was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: haematospermia. SEROPLEX dosage: 10 MG QD PO. Patient recovered.
SEROPLEX problem was reported by a Consumer or non-health professional from FRANCE on Nov 20, 2006. Male patient, 77 years of age, weighting 141.1 lb, was diagnosed with depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: prostatic specific antigen increased, urinary retention. SEROPLEX dosage: 10 MG QD PO. During the same period patient was treated with MOCLAMINE, COLCHICINE, TRANXENE, ZYPREXA. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported SEROPLEX problem on Nov 20, 2006. Male patient, 33 years of age, weighting 132.3 lb, was diagnosed with depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: arthralgia, asthenia, basophil count increased, hepatitis, hyperhidrosis, lymphocyte count increased, monocyte count increased, platelet count decreased, pyrexia. SEROPLEX dosage: 20 MG QD PO. During the same period patient was treated with ATARAX. Patient recovered.
SEROPLEX problem was reported by a Pharmacist from FRANCE on Nov 20, 2006. Male patient, 65 years of age, weighting 176.4 lb, was diagnosed with depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: dizziness, leukoencephalopathy, motor dysfunction, speech disorder, syncope, viral infection. SEROPLEX dosage: 10 MG QD PO. During the same period patient was treated with SEROPRAM, DEPAKOTE, LEPTICUR, SULFARLEM. Patient was hospitalized and became disabled. Patient recovered.
Health Professional from FRANCE reported SEROPLEX problem on Nov 21, 2006. Male patient, 43 years of age, weighting 205.0 lb, was diagnosed with depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: behcet's syndrome, condition aggravated, cytolytic hepatitis, dilatation atrial, dilatation ventricular, haemoglobin decreased, international normalised ratio increased, neutrophil count decreased. SEROPLEX dosage: 10 MG QD PO. During the same period patient was treated with MIRTAZAPINE, VALPROATE, AREDIA, ZOCOR, LORAZEPAM, NOCTRAN, CYCLOPHOSPHAMIDE, MESNA. Patient was hospitalized. Patient recovered.
SEROPLEX problem was reported by a Health Professional from FRANCE on Nov 20, 2006. Female patient, 77 years of age, was diagnosed with depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: burning sensation, depression, paraesthesia, skin burning sensation. SEROPLEX dosage: 10 MG QD PO. Patient was hospitalized. Patient recovered.
Health Professional from DENMARK reported SEROPLEX problem on Nov 24, 2006. Female patient, 19 years of age, was diagnosed with major depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: agitation, parasomnia, skin injury, sleep walking. SEROPLEX dosage: 10 MG QD PO. During the same period patient was treated with TRILEPTAL. Patient recovered.
SEROPLEX problem was reported by a Health Professional from FRANCE on Nov 28, 2006. Female patient, 41 years of age, was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: gingivitis ulcerative. SEROPLEX dosage: 10 MG QD PO. During the same period patient was treated with ATARAX, MAGNESIUM. Patient recovered.
Physician from FRANCE reported SEROPLEX problem on Dec 13, 2006. Female patient, 19 years of age, was diagnosed with major depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: agitation, parasomnia, skin injury, sleep walking. SEROPLEX dosage: 10 MG QD PO. During the same period patient was treated with TRILEPTAL. Patient recovered.
SEROPLEX problem was reported by a Physician from FRANCE on Nov 29, 2006. Female patient was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: constipation, urinary retention. SEROPLEX dosage: 15 MG QD PO. During the same period patient was treated with CORTICOSTEROIDS. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported SEROPLEX problem on Nov 29, 2006. Male patient, 48 years of age, was diagnosed with depression, hiv infection and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, cardiac aneurysm, coordination abnormal, csf lactate increased, facial palsy, gait disturbance, hypertriglyceridaemia, hypotension, loss of consciousness. SEROPLEX dosage: 15 MG QD PO. During the same period patient was treated with TERCIAN, NORVIR, TELZIR, ABACAVIR. Patient was hospitalized. Patient recovered.
SEROPLEX problem was reported by a Health Professional from DENMARK on Dec 05, 2006. Female patient, 41 years of age, was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: gingivitis ulcerative. SEROPLEX dosage: 10 MG QD PO. During the same period patient was treated with ATARAX, MAGNESIUM, PRAZEPAM. Patient recovered.
Consumer or non-health professional from FRANCE reported SEROPLEX problem on Dec 15, 2006. Male patient, 48 years of age, was diagnosed with depression, hiv infection and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: aneurysm, atrial septal defect, coordination abnormal, csf lactate increased, facial palsy, gait disturbance, hypertriglyceridaemia, hypotension, loss of consciousness. SEROPLEX dosage: 15 MG QD PO. During the same period patient was treated with TERCIAN, NORVIR, TELZIR, KIVEXA. Patient was hospitalized. Patient recovered.
SEROPLEX problem was reported by a Health Professional from FRANCE on Dec 05, 2006. Female patient, 41 years of age, was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: gingivitis ulcerative. SEROPLEX dosage: 10 MG QD PO. During the same period patient was treated with ATARAX, MAGNESIUM, PRAZEPAM. Patient recovered.
Consumer or non-health professional from FRANCE reported SEROPLEX problem on Dec 12, 2006. Male patient, 44 years of age, was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: epilepsy. SEROPLEX dosage: unknown. During the same period patient was treated with LAMICTAL, KEPPRA, ZOLPIDEM TARTRATE. Patient recovered.
SEROPLEX problem was reported by a Health Professional from FRANCE on Dec 15, 2006. Female patient, 45 years of age, was diagnosed with depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, discomfort, gamma-glutamyltransferase increased, hepatitis a antibody positive, pyrexia. SEROPLEX dosage: 20 MG QD PO. During the same period patient was treated with TERCIAN. Patient recovered.
Health Professional from FRANCE reported SEROPLEX problem on Dec 15, 2006. Female patient, 45 years of age, was diagnosed with depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, discomfort, gamma-glutamyltransferase increased, hepatitis a antibody positive, pyrexia. SEROPLEX dosage: 20 MG QD PO. During the same period patient was treated with TERCIAN. Patient recovered.
SEROPLEX problem was reported by a Health Professional from FRANCE on Dec 13, 2006. Female patient, 77 years of age, was diagnosed with depression and was treated with SEROPLEX. After drug was administered, patient experienced the following problems/side effects: paraesthesia. SEROPLEX dosage: 10 MG QD PO. Patient was hospitalized. Patient recovered.
Showing 1-75 of 109 Next >